- Home
- WU vs ICUI Comparison
WU vs ICUI Comparison
Compare WU & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WU
- ICUI
- Stock Information
- Founded
- WU 1851
- ICUI 1984
- Country
- WU United States
- ICUI United States
- Employees
- WU N/A
- ICUI N/A
- Industry
- WU Business Services
- ICUI Medical/Dental Instruments
- Sector
- WU Consumer Discretionary
- ICUI Health Care
- Exchange
- WU Nasdaq
- ICUI Nasdaq
- Market Cap
- WU 3.7B
- ICUI 3.6B
- IPO Year
- WU 2006
- ICUI 1992
- Fundamental
- Price
- WU $10.49
- ICUI $139.11
- Analyst Decision
- WU Hold
- ICUI Buy
- Analyst Count
- WU 10
- ICUI 4
- Target Price
- WU $12.11
- ICUI $199.67
- AVG Volume (30 Days)
- WU 5.9M
- ICUI 288.3K
- Earning Date
- WU 04-23-2025
- ICUI 05-06-2025
- Dividend Yield
- WU 8.97%
- ICUI N/A
- EPS Growth
- WU 63.09
- ICUI N/A
- EPS
- WU 2.74
- ICUI N/A
- Revenue
- WU $4,209,700,000.00
- ICUI $2,382,046,000.00
- Revenue This Year
- WU $1.69
- ICUI $0.21
- Revenue Next Year
- WU $1.71
- ICUI $2.47
- P/E Ratio
- WU $3.82
- ICUI N/A
- Revenue Growth
- WU N/A
- ICUI 5.44
- 52 Week Low
- WU $10.04
- ICUI $93.36
- 52 Week High
- WU $13.95
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- WU 44.46
- ICUI 40.91
- Support Level
- WU $10.38
- ICUI $142.83
- Resistance Level
- WU $10.67
- ICUI $152.06
- Average True Range (ATR)
- WU 0.25
- ICUI 5.75
- MACD
- WU -0.04
- ICUI 0.51
- Stochastic Oscillator
- WU 8.54
- ICUI 52.59
About WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of about 600,000 outside agents. The company handled over 270 million transactions in 2023 and is the largest money transfer company in the world.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.